Gedea Biotech
Gedea Biotech develops pHyph to treat and prevent the recurrence of bacterial vaginosis
Gedea Biotech has raised €1.3M across 1 funding round from 2 investors, most recently a round in May 2023. Based in Lund, Sweden; active in Healthtech. Data as of 28 Oct 2026.
Lund, Swedengedeabiotech.com ↗
Total raised
€1.3M
€1,300,000
Funding rounds
1
Investors
2
distinct backers
Active since
2023-05
latest 2023-05
Funding by year
EUR raised per yearGedea Biotech — funding by year — interactive chart.
Data table
| Gedea Biotech — funding by year | |
|---|---|
| 2023 | €1.3M |
Signals
Medium confidenceRaise-next likelihood6
base rate 30% for Other
- ▼ Past typical raise window
Timing: overdue vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2023-05-25 | Other | €1.3M | Angel Investors,Private Investors | View deal → |
Investors
2Angel InvestorsPrivate Investors
Related news
Similar companies
same sector or countryGlobal coverage: FundingData